| Literature DB >> 31296684 |
Mykhailo Savin1, Marijo Parcina2, Silvia Schmoger3, Judith Kreyenschmidt4, Annemarie Käsbohrer3,5, Jens A Hammerl6.
Abstract
Acinetobacter baumannii is an important human pathogen usually associated with severe hospital-acquired infections. Here, we announce the draft genome sequences of two livestock-associated isolates recovered from sewage water from a poultry slaughterhouse in Germany. Short-read whole-genome sequencing was conducted to determine the genetic basis of their antimicrobial resistance phenotype.Entities:
Year: 2019 PMID: 31296684 PMCID: PMC6624767 DOI: 10.1128/MRA.00553-19
Source DB: PubMed Journal: Microbiol Resour Announc ISSN: 2576-098X
Genetic features of Acinetobacter baumannii isolates LWGS-03-02-11A and LWGS-03-02-11B
| Feature | Data for | |
|---|---|---|
| LWGS-03-02-11A | LWGS-03-02-11B | |
| Parameters | ||
| No. of reads (total) | 2,284,028 | 2,911,344 |
| Avg read length (bp) | 147.73 | 147.83 |
| No. of contigs | 90 | 103 |
| | 159,782 | 159,782 |
| | 8 | 8 |
| Genome coverage (×) | >35 | >45 |
| Genome | ||
| Size (bp) | 3,983,337 | 3,982,846 |
| GC content (%) | 38.90 | 38.89 |
| Genetic elements | ||
| Total genes | 3,925 | 3,852 |
| Total CDS | 3,854 | 3,781 |
| Coding genes | 3,744 | 3,672 |
| Coding CDS | 3,744 | 3,672 |
| RNA genes | 71 | 71 |
| rRNAs (5S, 16S, 23S) | 1, 1, 1 | 1, 1, 1 |
| tRNAs | 64 | 64 |
| ncRNAs | 4 | 4 |
| Pseudogenes (no.) | ||
| Total | 110 | 109 |
| Ambiguous residues | 0 | 0 |
| Frameshifted | 41 | 40 |
| Incomplete | 60 | 60 |
| Internal stop | 26 | 26 |
| Multiple problems | 15 | 15 |
| MLST | ||
| Abaumanni1 | ST-836 | ST-836 |
| Abaumanni2 | ST-388 | ST-388 |
| Database accession no. | ||
| GenBank no. | ||
| BioProject no. | ||
| BioSample no. | ||
| Genetic resistance determinants | ||
| Beta-lactams (%) | ||
| Phenotypic resistance (MIC, mg/liter) | ||
| Ampicillin | 8 | 8 |
| Azithromycin | ≤2 | ≤2 |
| Cefepime | 1 | 1 |
| Chloramphenicol | 32 | 32 |
| Ciprofloxacin | 0.06 | 0.06 |
| Colistin | ≤1 | ≤1 |
| Ertapenem | 1 | 1 |
| Cefotaxime | 8 | 8 |
| Cefoxitin | 64 | 64 |
| Gentamicin | 1 | 1 |
| Imipenem | 0.25 | 0.25 |
| Meropenem | 0.25 | 0.25 |
| Nalidixic acid | ≤4 | ≤4 |
| Sulfamethoxazole | ≤8 | ≤8 |
| Ceftazidime | 2 | 2 |
| Temocillin | >128 | >128 |
| Tetracycline | ≤2 | ≤2 |
| Tigecycline | ≤0.25 | ≤0.25 |
| Trimethoprim | 16 | 16 |
Both isolates were obtained in 2018 from sewage water in Germany.
CDS, coding sequences; ncRNAs, noncoding RNAs.
In silico analysis was conducted using the Web-based tool MLST finder 2.0 (software version 2.0.1) (for MLST data) and ResFinder 3.1 (software version 3.1.0) (for genetic resistance determinants) of the Center for Genomic Epidemiology (http://www.genomicepidemiology.org/). The percentages of nucleotide identity of the target sequence to the reference are given in parentheses, and the number of nucleotides covered by the identified resistance gene and that of the respective reference gene are given in brackets.
Resistance testing was conducted according to the guidelines of the CLSI.